Your session is about to expire
← Back to Search
Other
Questionnaire Administration for Cancer
N/A
Waitlist Available
Led By Jay Burmeister, PhD
Research Sponsored by Barbara Ann Karmanos Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
Study Summary
This trial is testing whether giving patients direct access to a medical physicist, who can answer their questions about cancer treatment, will help reduce anxiety and distress during treatment.
Eligible Conditions
- Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Anxiety
Distress
Secondary outcome measures
Patient treatment adherence
Side effects data
From 2020 Phase 3 trial • 177 Patients • NCT0181707513%
Rash maculo-papular
10%
Skin and subcutaneous tissue disorders - Other, specify
1%
Mucositis oral
1%
Sepsis
1%
Skin ulceration
1%
Urticaria
100%
80%
60%
40%
20%
0%
Study treatment Arm
Arm I (CHG Cleansing Wipe)
Arm II (Control)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm II (printed materials, physicist interaction)Experimental Treatment3 Interventions
Patients receive printed materials as in Arm I. Patients also receive a minimum of 2 direct physicist interactions to describe the technical aspects of their treatment either immediately prior to or immediately after treatment simulation.
Group II: Arm I (printed materials)Active Control2 Interventions
Patients receive printed materials describing the technical aspects of their treatment.
Find a Location
Who is running the clinical trial?
Barbara Ann Karmanos Cancer InstituteLead Sponsor
163 Previous Clinical Trials
9,241 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,416 Total Patients Enrolled
Jay Burmeister, PhDPrincipal Investigator - Barbara Ann Karmanos Institute
Barbara Ann Karmanos Cancer Institute
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger